NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
175 hedge funds and large institutions have $1.61B invested in NxStage Medical Inc. in 2018 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 21 closing their positions.
33% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 21
2% more funds holding
Funds holding: 171 → 175 (+4)
1% more capital invested
Capital invested by funds: $1.59B → $1.61B (+$17.1M)
2% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 54
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
36% less call options, than puts
Call options by funds: $1.97M | Put options by funds: $3.08M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$34.3M |
| 2 |
GL
Governors Lane
New York
|
+$22.9M |
| 3 |
TAL
TIG Advisors LLC
New York
|
+$18.2M |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$17.4M |
| 5 |
JP Morgan Chase
New York
|
+$12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Flossbach Von Storch
Cologne,
Germany
|
-$46.7M |
| 2 |
AWG
Alpha Wave Global
New York
|
-$22.1M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$14.5M |
| 4 |
OP
Omni Partners
London,
United Kingdom
|
-$11.5M |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$11.4M |
NXTM Hedge Fund Activity: Q3 2018 in Review
175 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2018, worth a combined $1.61B — up 1.1% from $1.59B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new NXTM positions and 21 closed out — a net gain of 7 holders — while 53 added to existing stakes and 54 trimmed.
The largest buyer was Millennium Management, adding an estimated $34.3M. The largest seller was Flossbach Von Storch, cutting an estimated $46.7M.
- 175 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2018, up from 171 in Q2 2018.
- Funds reported $1.61B of NxStage Medical Inc. stock for Q3 2018, up 1.1% quarter-over-quarter.
- 28 funds opened new NxStage Medical Inc. positions in Q3 2018 and 21 closed out, a net change of +7 holders.
- The largest NxStage Medical Inc. buyer in Q3 2018 was Millennium Management, an estimated $34.3M added.
- The largest NxStage Medical Inc. seller in Q3 2018 was Flossbach Von Storch, an estimated $46.7M sold.
Based on aggregated 13F filings for Q3 2018.